[SLN] YoY Quarter Result on 31-Mar-2018 [#Q1]

Stock
[SLN] Silence Therapeutics plc
Announcement Date
30-Mar-2018
Financial Year
2018
Quarter
31-Mar-2018 [#Q1]
Profit Trend
QoQ- -322.88%
YoY- -57.51%
Quarter Report
SLN's Result
SLN's Financial Summary
View:
Show?
Quarter Result
31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 CAGR
Revenue 3,144 573 0 0 8 0 0 -
PBT -9,870 -6,665 -4,799 -4,894 -3,328 -2,771 -2,071 29.69%
Tax -1,450 1,150 694 550 570 405 0 -
NP -8,420 -5,515 -4,105 -4,344 -2,758 -2,367 -2,071 26.30%
Tax Rate - - - - - - - -
Total Cost 11,564 6,088 4,105 4,344 2,766 2,367 2,071 33.16%
Ratio Analysis
31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 CAGR
NP Margin -267.81 -962.39 0.00 0.00 -34,475.00 0.00 0.00 -
Per Share
31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 CAGR
EPS -0.29 -0.21 -0.17 -0.19 -0.12 -0.10 -0.11 17.51%
EPS Diluted -0.29 -0.21 -0.17 -0.19 -0.12 -0.10 -0.11 17.51%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.